115 related articles for article (PubMed ID: 10432686)
1. Phosphorylation of anti-HIV nucleoside analogs by nucleoside diphosphate kinase.
Schneider B; Xu Y; Sellam O; Sarfati R; Janin J; Véron M; Deville-Bonne D
Nucleosides Nucleotides; 1999; 18(4-5):829-30. PubMed ID: 10432686
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs.
Schneider B; Sarfati R; Deville-Bonne D; Véron M
J Bioenerg Biomembr; 2000 Jun; 32(3):317-24. PubMed ID: 11768316
[TBL] [Abstract][Full Text] [Related]
3. Antiviral nucleoside analogs phosphorylation by nucleoside diphosphate kinase.
Gallois-Montbrun S; Veron M; Deville-Bonne D
Mini Rev Med Chem; 2004 May; 4(4):361-9. PubMed ID: 15134539
[TBL] [Abstract][Full Text] [Related]
4. NDP kinase reactivity towards 3TC nucleotides.
Kreimeyer A; Schneider B; Sarfati R; Faraj A; Sommadossi JP; Veron M; Deville-Bonne D
Antiviral Res; 2001 May; 50(2):147-56. PubMed ID: 11369435
[TBL] [Abstract][Full Text] [Related]
5. Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides.
Schneider B; Xu YW; Sellam O; Sarfati R; Janin J; Veron M; Deville-Bonne D
J Biol Chem; 1998 May; 273(19):11491-7. PubMed ID: 9565562
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of phosphorylation of anti-HIV D4T by nucleoside diphosphate kinase.
Schneider B; Biondi R; Sarfati R; Agou F; Guerreiro C; Deville-Bonne D; Veron M
Mol Pharmacol; 2000 May; 57(5):948-53. PubMed ID: 10779378
[TBL] [Abstract][Full Text] [Related]
7. The catalytic mechanism of nucleoside diphosphate kinases.
Lascu I; Gonin P
J Bioenerg Biomembr; 2000 Jun; 32(3):237-46. PubMed ID: 11768307
[TBL] [Abstract][Full Text] [Related]
8. Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase.
Bourdais J; Biondi R; Sarfati S; Guerreiro C; Lascu I; Janin J; Véron M
J Biol Chem; 1996 Apr; 271(14):7887-90. PubMed ID: 8626464
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of phosphorylation of natural nucleosides and anti-HIV analogues by nucleoside diphosphate kinase is independent of their sugar substituents.
Hutter MC; Helms V
Chembiochem; 2002 Jul; 3(7):643-51. PubMed ID: 12324998
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of nucleoside diphosphate kinase at the active site studied by steady-state and time-resolved fluorescence.
Deville-Bonne D; Sellam O; Merola F; Lascu I; Desmadril M; Véron M
Biochemistry; 1996 Nov; 35(46):14643-50. PubMed ID: 8931563
[TBL] [Abstract][Full Text] [Related]
11. 3'-Phosphorylated nucleotides are tight binding inhibitors of nucleoside diphosphate kinase activity.
Schneider B; Xu YW; Janin J; Véron M; Deville-Bonne D
J Biol Chem; 1998 Oct; 273(44):28773-8. PubMed ID: 9786875
[TBL] [Abstract][Full Text] [Related]
12. Adenosine phosphonoacetic acid is slowly metabolized by NDP kinase.
Chen Y; Morera S; Pasti C; Angusti A; Solaroli N; Véron M; Janin J; Manfredini S; Deville-Bonne D
Med Chem; 2005 Nov; 1(6):529-36. PubMed ID: 16787337
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside mono- and diphosphate prodrugs of 2',3'-dideoxyuridine and 2',3'-dideoxy-2',3'-didehydrouridine.
Pertenbreiter F; Balzarini J; Meier C
ChemMedChem; 2015 Jan; 10(1):94-106. PubMed ID: 25209965
[TBL] [Abstract][Full Text] [Related]
14. Activation of anti-reverse transcriptase nucleotide analogs by nucleoside diphosphate kinase: improvement by alpha-boranophosphate substitution.
Schneider B; Meyer P; Sarfati S; Mulard L; Guerreiro C; Boretto J; Janin J; Véron M; Deville-Bonne D; Canard B
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):297-306. PubMed ID: 11563041
[TBL] [Abstract][Full Text] [Related]
15. Improving nucleoside diphosphate kinase for antiviral nucleotide analogs activation.
Gallois-Montbrun S; Schneider B; Chen Y; Giacomoni-Fernandes V; Mulard L; Morera S; Janin J; Deville-Bonne D; Veron M
J Biol Chem; 2002 Oct; 277(42):39953-9. PubMed ID: 12171931
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside diphosphate prodrugs.
Meier C; Jessen HJ; Balzarini J
Nucleic Acids Symp Ser (Oxf); 2008; (52):83-4. PubMed ID: 18776264
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a soluble nucleoside diphosphate kinase in Trypanosoma cruzi.
Ulloa RM; Muschietti JP; Veron M; Torres HN; Tellez-Iñón MT
Mol Biochem Parasitol; 1995 Mar; 70(1-2):119-29. PubMed ID: 7637692
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside diphosphate kinase and the activation of antiviral phosphonate analogs of nucleotides: binding mode and phosphorylation of tenofovir derivatives.
Koch K; Chen Y; Feng JY; Borroto-Esoda K; Deville-Bonne D; Gallois-Montbrun S; Janin J; Moréra S
Nucleosides Nucleotides Nucleic Acids; 2009 Aug; 28(8):776-92. PubMed ID: 20183617
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide affinity for a stable phosphorylated intermediate of nucleoside diphosphate kinase.
Schneider B; Norda A; Karlsson A; Veron M; Deville-Bonne D
Protein Sci; 2002 Jul; 11(7):1648-56. PubMed ID: 12070317
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases.
Van Rompay AR; Johansson M; Karlsson A
Pharmacol Ther; 2000; 87(2-3):189-98. PubMed ID: 11008000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
